John Barr Corporate Vice President and President, Global Surgical John Barr is Executive Vice President and Global President of Bausch + Lomb's Surgical business. He was named to this post in May 2012, and reports to Bausch + Lomb's President and CEO, Brent Saunders. Mr. Barr has extensive medical device and biotechnology industry experience spanning a wide variety of operational, strategy and customer-facing roles in which he consistently increased company value and delivered business results. At Bausch + Lomb, Mr. Barr has global responsibility for the company's full suite of ophthalmic surgical products, intraocular lenses (IOLs) and delivery systems, which include such brand names as enVista™ Crystalens®, Stellaris® PC, Storz™and VICTUS™. Immediately prior to joining Bausch + Lomb, Barr was President and CEO of AGA Medical, a pioneer of minimally invasive devices to treat structural heart defects and vascular abnormalities. Under his leadership, AGA Medical, which had been a Welsh Carson Anderson and Stowe-owned portfolio company, completed a successful IPO before ultimately being acquired by St. Jude Medical. Barr also spent more than eight years at V.I. Technologies, an anti-infective therapeutics company as its President and COO. Prior to joining V. I. Technologies, Barr spent seven years with Haemonetics, a manufacturer of blood processing technology, in a variety of customer service and operations roles before ultimately being named President of North American Operations. Earlier in his career, Barr spent nearly 10 years at Baxter Healthcare in a number of financial and operational assignments culminating with his being promoted to Vice President of the company's healthcare IT solutions division, which ultimately merged with IBM Hospital Systems. Barr is a graduate of the J. L. Kellogg Graduate School of Management-Northwestern University in Evanston, IL where he earned his master's degree in Accounting and Economics. He earned his undergraduate degree in Bioengineering from the University of Pennsylvania in Philadelphia, PA. Barr is also a former member of the Board of Directors for AdvaMed.

John Barr Corporate Vice President and President, Global Surgical John Barr is Executive Vice President and Global President of Bausch + Lomb's Surgical business. He was named to this post in May 2012, and reports to Bausch + Lomb's President and CEO, Brent Saunders. Mr. Barr has extensive medical device and biotechnology industry experience spanning a wide variety of operational, strategy and customer-facing roles in which he consistently increased company value and delivered business results. At Bausch + Lomb, Mr. Barr has global responsibility for the company's full suite of ophthalmic surgical products, intraocular lenses (IOLs) and delivery systems, which include such brand names as enVista™ Crystalens®, Stellaris® PC, Storz™and VICTUS™. Immediately prior to joining Bausch + Lomb, Barr was President and CEO of AGA Medical, a pioneer of minimally invasive devices to treat structural heart defects and vascular abnormalities. Under his leadership, AGA Medical, which had been a Welsh Carson Anderson and Stowe-owned portfolio company, completed a successful IPO before ultimately being acquired by St. Jude Medical. Barr also spent more than eight years at V.I. Technologies, an anti-infective therapeutics company as its President and COO. Prior to joining V. I. Technologies, Barr spent seven years with Haemonetics, a manufacturer of blood processing technology, in a variety of customer service and operations roles before ultimately being named President of North American Operations. Earlier in his career, Barr spent nearly 10 years at Baxter Healthcare in a number of financial and operational assignments culminating with his being promoted to Vice President of the company's healthcare IT solutions division, which ultimately merged with IBM Hospital Systems. Barr is a graduate of the J. L. Kellogg Graduate School of Management-Northwestern University in Evanston, IL where he earned his master's degree in Accounting and Economics. He earned his undergraduate degree in Bioengineering from the University of Pennsylvania in Philadelphia, PA. Barr is also a former member of the Board of Directors for AdvaMed.

John Barr, who has served as Chief Operating Officer of AGA since September 2005 under Franck Gougeon, has been named President and CEO of AGA. Franck Gougeon commented, "John and I have worked closely in the past few years to build the Company and strengthen the management team. Mr. Barr's prior experience includes serving as CEO of V.I. Technologies, a development stage company, President of North American Operations and a member of the Board of Directors for Haemonetics Corporation and in a variety of roles at Baxter Healthcare. Mr. Barr has a B.S. in Bioengineering from the University of Pennsylvania and an MBA from the Kellogg School of Management at Northwestern University.

John R. Barr President and Chief Executive Officer John R. Barr President and Chief Executive Officer John R. Barr has served as the President and Chief Executive Officer since June 2008 and, prior to that served as the Chief Operating Officer since September 2005. Prior to joining the company, Mr. Barr served as President and Chief Executive Officer of V.I. Technologies prior to its merger with Panacos Pharmaceuticals in 2005. Prior to joining V.I. Technologies, Mr. Barr served from June 1990 to November 1997 as President of North American Operations for Haemonetics Corporation, a leading medi... 

The other two current Class I Directors, Dr. Richard Charpie and Mr. John Barr, are not standing for re-election to the Board.John R. Barr, age 48, joined our company as President, Chief Executive Officer and a director in November 1997.With the merger with Panacos in March 2005, Mr. Barr remains as President and a director.Previously, Mr. Barr served as President of North American Operations at Haemonetics Corporation from 1995 to 1997 where he had responsibility for Haemonetics' blood bank, commercial plasma and blood bank services businesses.He also managed the global manufacturing and North American research and development functions and served as a member of the Board of Directors of Haemonetics.Prior to joining Haemonetics in 1990, he held various positions at Baxter Healthcare Corporation.Mr. Barr has an undergraduate degree in Biomedical Engineering from the University of Pennsylvania and an M.M. from the Kellogg School of Management at Northwestern University. The Committee was composed of Mr. David Tendler, Mr. John Barr, and Dr. Richard Charpie, with Mr. Tendler, who resigned from our Board in March 2005, serving as Chairman.Mr. Barr is the President of Vitex.Prior to the merger with Panacos in March 2005, Mr. Barr served as Chief Executive Officer of Vitex.